Jade Biosciences (JBIO) Other financing activities (2021 - 2026)
Jade Biosciences posted quarterly Other financing activities of $31000.0 for Q1 2026, down 95.57% year-on-year from $700000.0 in Q1 2025, and up 102.31% on a QoQ basis from -$1.3 million in Q4 2025.
Jade Biosciences (JBIO) has 6 years of Other financing activities data on file, last reported at $31000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities fell 95.57% year-over-year to $31000.0; the trailing twelve-month figure through Mar 2026 stood at $188.4 million (up 4608.7% YoY), and the FY2025 full-year result was $189.1 million, up 61499.67% from the prior year.
- Other financing activities for Q1 2026 stood at $31000.0, up from -$1.3 million in the prior quarter.
- Across five years, Other financing activities topped out at $189.8 million in Q2 2025 and bottomed at -$1.3 million in Q4 2025.
- The 5-year median for Other financing activities is $230500.0 (2024), against an average of $19.3 million.
- Peak annual rise in Other financing activities reached 256321.62% in 2025, while the deepest fall reached 144.7% in 2025.
- A 5-year view of Other financing activities shows it stood at $236000.0 in 2022, then plunged by 68.22% to $75000.0 in 2023, then jumped by 3900.0% to $3.0 million in 2024, then tumbled by 144.7% to -$1.3 million in 2025, then jumped by 102.31% to $31000.0 in 2026.
- The last three Other financing activities figures came in at $31000.0 (Q1 2026), -$1.3 million (Q4 2025), and $189.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jade Biosciences | 1.06 Bn | 1.06 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31,000.00 |
| Mar 31, 2026 | 31,000.00 |
| Dec 31, 2025 | -1.34 Mn |
| Dec 31, 2025 | -1.34 Mn |
| Jun 30, 2025 | 189.75 Mn |
| Jun 30, 2025 | 189.75 Mn |
| Mar 31, 2025 | 700,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Dec 31, 2024 | 3.00 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 228,000.00 |
| Sep 30, 2024 | 228,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Mar 31, 2024 | 233,000.00 |
| Mar 31, 2024 | 233,000.00 |
| Sep 30, 2023 | 75,000.00 |
| Sep 30, 2023 | 75,000.00 |
| Dec 31, 2022 | 236,000.00 |
| Dec 31, 2022 | 236,000.00 |
| Jun 30, 2021 | 1.02 Mn |
| Jun 30, 2021 | 1.02 Mn |
| Mar 31, 2021 | 100,000.00 |
| Mar 31, 2021 | 100,000.00 |